Additional Information
| Specialty | |
|---|---|
| Manufacturer | |
| Brand |
Macroplastique Mild SUI
Urethral Bulking for the Treatment of SUI in Males and Females
Macroplastique is an injectable soft-tissue bulking agent used to treat stress urinary incontinence (SUI).
The Macroplastique advantage
- Unique delivery system ensures precise implantation
- May be performed in the office
- Permanent implants: non-degradable, non-resorbable
- Soft, flexible, textured implant particles create an excellent matrix for collagen deposition
- Histological examination of tissue explants revealed no evidence of particle migration
Proven performance
In a multi-center clinical study¹, Macroplastique demonstrated excellent clinical efficacy:
- 122 patients received Macroplastique and were followed for 12 months from initial treatment
- 75 of 122 (61.5%) were improved at 12 months based on Stamey grade
- 45 of 122 (36.8%) were dry based on Stamey grade
No serious treatment-related adverse events were associated with Macroplastique procedures. Twenty-four month follow-up data were available on 84 Macroplastique subjects. Of these 84 subjects, 63 had improvement in Stamey Grade at 24 months, 28 of whom were dry.
References
1. Ghoniem, G. et al. (2009). J Urol. 181, 204-210. Cross-linked polydimethylsiloxane injection for female stress urinary incontinence: Results of a multicenter, randomised, controlled, single-blind study¹
